Yair Lotan
University of Texas Southwestern Medical Center
CancerInternal medicineRadiologyUrologySurgeryPathologyOncologyStage (cooking)CystectomyCarcinomaLymphovascular invasionDiseaseProstate cancerBladder cancerGynecologyIn patientUrothelial carcinomaProportional hazards modelMedicineCohort
1,020Publications
107H-index
31.5kCitations
Publications 1044
Newest
#1Samuel GoldH-Index: 7
Last. Yair LotanH-Index: 107
view all 4 authors...
Source
#1Anirban P. MitraH-Index: 28
#2Vikram M. NarayanH-Index: 10
Last. Jeffrey S. MontgomeryH-Index: 31
view all 43 authors...
INTRODUCTION AND OBJECTIVE:Nadofaragene firadenovec is a recombinant adenoviral vector-based intravesical therapeutic that delivers a copy of human IFNα2b gene to urothelial cells. A recent phase 3...
Source
#1Eric A. KleinH-Index: 116
#2Alan W. PartinH-Index: 124
Last. Hui ZhuH-Index: 6
view all 16 authors...
INTRODUCTION AND OBJECTIVE:We present cumulative results describing the clinical performance of IsoPSA, a blood-based, structure-focused assay for high grade prostate cancer, in a large scale, pros...
Source
Source
#2Samuel GoldH-Index: 7
Last. Yair LotanH-Index: 107
view all 4 authors...
Source
Source
#1Caleb AshbrookH-Index: 1
#2Raj R. BhanvadiaH-Index: 4
Last. Solomon L. WolduH-Index: 13
view all 6 authors...
Source
#1Anne SchuckmanH-Index: 19
#2Yair LotanH-Index: 107
Last. Colin P. DinneyH-Index: 104
view all 5 authors...
INTRODUCTION AND OBJECTIVE:Despite optimal treatment (tx), patients (pts) with BCG-unresponsive NMIBC remain at significant risk for recurrence and progression and thus an unmet medical need exists...
Source
#1Samuel GoldH-Index: 7
Last. Yair LotanH-Index: 107
view all 3 authors...
Source
Source